RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Development of pharmacogenomic algorithm to optimize nateglinide dose for the treatment of type 2 diabetes mellitus.

Development of pharmacogenomic algorithm to optimize nateglinide dose for the treatment of type 2 diabetes mellitus.

Add to Collection
2022 Oct Others SM Naushad, T Hussain, SA Alrokayan… - Pharmacological …, 2022 - Springer

Full Author : ['Naushad, Shaik Mohammad', 'Hussain, Tajamul', 'Alrokayan, Salman A', 'Kutala, Vijay Kumar']
Journal Title : Pharmacological reports : PR
Chapter : Section1, Section3
Journal Year : 2022
Cited by : 2.0

BACKGROUND: Nateglinide is a meglitinide used for the treatment of type 2 diabetes mellitus. Individual studies demonstrated the association of CYP2C9, SLCO1B1, and MTNR1B variants with the safety and efficacy of nateglinide. The current study aimed to de..... Read More

Keywords : ["type diabetes mellitus", "optimize nateglinide dose", "pharmacogenomic algorithm", "treatment", "development"]
PubMed Link : https://link.springer.com/article/10.1007/s43440-022-00400-0
Google Scholar Link : https://scholar.google.com/scholar?cites=17898742019885174758&as_sdt=5,44&sciodt=0,44&hl=en&num=20